Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lyconist Fort is an oral syrup developed and marketed by Venistro Biotech, primarily positioned for use in the field of gynecology. It is a combination formulation that typically includes lycopene, multivitamins, and multiminerals. The primary active component, lycopene, is a potent carotenoid antioxidant that helps neutralize reactive oxygen species (ROS) and mitigate oxidative stress, which is often implicated in various reproductive health issues. The additional vitamins and minerals in the syrup serve as nutritional supplements to support general metabolic health and address deficiencies, particularly during pregnancy or for overall gynecological wellness. As a marketed product in the Indian pharmaceutical sector, it is utilized as a supportive therapy for maintaining reproductive health and managing conditions associated with oxidative damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lyconist Fort.